WAM
Wakefield Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.12M | Sell |
17,108
-140
| -0.8% | -$9.14K | 0.31% | 106 |
|
|
2025
Q1 | $1.15M | Buy |
+17,248
| New | +$1.15M | 0.35% | 87 |
|
|
2024
Q4 | – | Sell |
-13,819
| Closed | -$824K | – | 148 |
|
|
2024
Q3 | $824K | Sell |
13,819
-167
| -1% | -$9.96K | 0.27% | 109 |
|
|
2024
Q2 | $891K | Sell |
13,986
-177
| -1% | -$11.3K | 0.31% | 100 |
|
|
2024
Q1 | $979K | Buy |
+14,163
| New | +$979K | 0.34% | 84 |
|
|
2023
Q4 | – | Sell |
-12,350
| Closed | -$717K | – | 151 |
|
|
2023
Q3 | $717K | Sell |
12,350
-5,125
| -29% | -$298K | 0.32% | 87 |
|
|
2023
Q2 | $941K | Buy |
+17,475
| New | +$941K | 0.37% | 73 |
|